Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, ThermoFisher, and other distributors ...
Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST...
Agreement Enhances Precipio’s Product Reach to US Laboratories...
Meeting Adjourned, new meeting set for July 5th at 10am EDT...
Seasoned, experienced industry executive with a track record of managing 9-figure revenue sales organizations...
This Regulatory Approval Opens the Company’s Reach to the European Market...
Laboratory operating both HemeScreen® & IV-Cell® demonstrates significant cross-sell potential...
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its...
Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST...
NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl...